Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aelis Farma

Aelis Farma
2013 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$9.9M LATEST DEAL AMOUNT
10 INVESTORS
Description

Developer of signaling specific therapeutics designed for the treatment of cannabis abuse. The company's signaling specific therapeutics specializes in the development of first-in-class CB1 (cannabinoid receptor) signaling specific inhibitors targeting cannabis abuse, enabling physicians to provide proper feedback on treatment progress.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Neurocentre Magendie
  • 146, rue Léo Saignat
  • 33077 Bordeaux
  • France

+33 05 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aelis Farma’s full profile, request a free trial.

Aelis Farma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 13-Dec-2019 $9.9M 00.00 Completed Startup
7. Later Stage VC 13-Dec-2019 00.000 00.00 Completed Startup
6. Early Stage VC 20-Dec-2017 00.000 00.000 000.00 Completed Startup
5. Early Stage VC 11-Jun-2017 00000 00.000 00.000 Completed Startup
4. Grant 07-Oct-2015 00000 00.00 Completed Startup
3. Grant 00.000 00.00 Completed Startup
2. Seed Round 27-Mar-2014 $2.03M $2.3M 00.000 Completed Startup
1. Seed Round 16-Dec-2013 $272K $272K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Aelis Farma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
ABSA2014 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 58,000 $0.011826 $29.97 $29.97 1x $29.97 19.69%
Ordinary 50,000 $0.011826 $4.73 $4.73 1x $4.73 16.98%
To view this company’s complete Cap Table, request access »

Aelis Farma Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aquitaine-Creation-Innovation Venture Capital Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Irdi Soridec Gestion Asset Manager Minority 000 0000 000000 0
Le Conseil régional d'Aquitaine Other Minority 000 0000 000000 0
National Angel Capital Organization Other Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Aelis Farma Executive Team (7)

Name Title Board
Seat
Contact
Info
Pier Piazza Ph.D Co-Founder, Chief Executive Officer & Board Member
Valérie Scappaticci Co-Founder & Chief Financial Officer
Sandy Fabre Ph.D Co-Founder & Head of Chemistry and Pharmaceutical development
Stéphanie Monlezun Ph.D Co-Founder & Head of Project Management
Giovanni Marsicano Ph.D Co-Founder
You’re viewing 5 of 7 executives. Get the full list »

Aelis Farma Board Members (5)

Name Representing Role Since Contact
Info
Alain Sainsot Aelis Farma Board Member 000 0000
François Thomas MD Aelis Farma Chairman 000 0000
Pier Piazza Ph.D Aelis Farma Co-Founder, Chief Executive Officer & Board Member 000 0000
Thibaut Richebois Aelis Farma Board Member 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »